Seth H. Blum

906 total citations
23 papers, 546 citations indexed

About

Seth H. Blum is a scholar working on Physiology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Seth H. Blum has authored 23 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 7 papers in Pharmacology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Seth H. Blum's work include Pharmacology and Obesity Treatment (6 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Attention Deficit Hyperactivity Disorder (4 papers). Seth H. Blum is often cited by papers focused on Pharmacology and Obesity Treatment (6 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Attention Deficit Hyperactivity Disorder (4 papers). Seth H. Blum collaborates with scholars based in United States, Taiwan and Spain. Seth H. Blum's co-authors include Thomas J.H. Chen, Kenneth Blum, Eric R. Braverman, Bernard W. Downs, Roger L. Waite, Vanessa Arcuri, Mallory Kerner, Tomás Palomo, Thomas J. Prihoda and Patrick Rhoades and has published in prestigious journals such as Advances in Therapy, Journal of Psychoactive Drugs and Medical Hypotheses.

In The Last Decade

Seth H. Blum

23 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Seth H. Blum United States 14 247 214 126 118 116 23 546
Mallory Kerner United States 16 252 1.0× 221 1.0× 137 1.1× 113 1.0× 137 1.2× 24 628
Roger L. Waite United States 18 341 1.4× 282 1.3× 180 1.4× 148 1.3× 175 1.5× 29 756
John Giordano United States 16 323 1.3× 237 1.1× 175 1.4× 100 0.8× 141 1.2× 38 747
Andrea Dlugos United States 14 265 1.1× 105 0.5× 221 1.8× 71 0.6× 135 1.2× 17 731
Jeffrey L. Rausch United States 18 236 1.0× 168 0.8× 202 1.6× 111 0.9× 88 0.8× 29 772
Aram El Khoury Sweden 15 318 1.3× 105 0.5× 87 0.7× 102 0.9× 71 0.6× 25 733
Dorottya Pap Hungary 16 107 0.4× 165 0.8× 91 0.7× 72 0.6× 125 1.1× 34 623
Hristina Jovanovic Sweden 9 204 0.8× 104 0.5× 72 0.6× 56 0.5× 149 1.3× 10 613
J. Stastny Austria 14 329 1.3× 146 0.7× 162 1.3× 74 0.6× 159 1.4× 28 863
Klas R. Linderholm Sweden 12 163 0.7× 415 1.9× 159 1.3× 69 0.6× 50 0.4× 14 1.2k

Countries citing papers authored by Seth H. Blum

Since Specialization
Citations

This map shows the geographic impact of Seth H. Blum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seth H. Blum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seth H. Blum more than expected).

Fields of papers citing papers by Seth H. Blum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seth H. Blum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seth H. Blum. The network helps show where Seth H. Blum may publish in the future.

Co-authorship network of co-authors of Seth H. Blum

This figure shows the co-authorship network connecting the top 25 collaborators of Seth H. Blum. A scholar is included among the top collaborators of Seth H. Blum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seth H. Blum. Seth H. Blum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blum, Kenneth, Roger L. Waite, Seth H. Blum, et al.. (2014). Hypothesizing “Reward” Gene Polymorphisms May Predict High Rates of Injury and Addiction in the Workforce: A Nutrient and Electrotherapeutic Based Solution. Health. 6(16). 2261–2285. 1 indexed citations
2.
Blum, Kenneth, Bernard W. Downs, Eric R. Braverman, et al.. (2010). Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE®device therapy: a case series. Cases Journal. 3(1). 54–54. 5 indexed citations
3.
4.
Blum, Kenneth, Abdalla Bowirrat, Roger L. Waite, et al.. (2009). Putative targeting of Dopamine D2 receptor function in Reward Deficiency Syndrome (RDS) by Synaptamine Complex™ Variant (KB220): Clinical trial showing anti-anxiety effects. 15 indexed citations
5.
Blum, Kenneth, Amanda LC Chen, Thomas J.H. Chen, et al.. (2008). LG839: Anti-obesity effects and polymorphic gene correlates of reward deficiency syndrome. Advances in Therapy. 25(9). 894–913. 41 indexed citations
6.
Blum, Kenneth, Thomas J.H. Chen, Eric R. Braverman, et al.. (2008). Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary. Theoretical Biology and Medical Modelling. 5(1). 24–24. 112 indexed citations
7.
Chen, Amanda LC, Thomas J.H. Chen, Roger L. Waite, et al.. (2008). Hypothesizing that brain reward circuitry genes are genetic antecedents of pain sensitivity and critical diagnostic and pharmacogenomic treatment targets for chronic pain conditions. Medical Hypotheses. 72(1). 14–22. 36 indexed citations
8.
Chen, Amanda LC, Thomas J.H. Chen, Eric R. Braverman, et al.. (2008). Hypothesizing that Marijuana Smokers are at a Significantly Lower Risk of Carcinogenicity Relative to Tobacco-Non-Marijuana Smokers: Evidenced Based on Statistical Reevaluation of Current Literature. Journal of Psychoactive Drugs. 40(3). 263–272. 9 indexed citations
9.
Blum, Kenneth, Thomas J.H. Chen, William B. Downs, et al.. (2008). A short term pilot open label study to evaluate efficacy and safety of LG839, a customized DNA directed nutraceutical in obesity: Exploring Nutrigenomics. 12(2). 371–382. 23 indexed citations
10.
Blum, Kenneth, Thomas J.H. Chen, Amanda LC Chen, et al.. (2008). Dopamine D2 receptor Taq A1 allele predicts treatment compliance of LG839 in a subset analysis of pilot study in the Netherlands. 12(1). 129–140. 33 indexed citations
11.
Chen, Thomas J.H., Kenneth Blum, Roger L. Waite, et al.. (2007). Gene Narcotic Attenuation Program attenuates substance use disorder, a clinical subtype of reward deficiency syndrome. Advances in Therapy. 24(2). 402–414. 25 indexed citations
12.
13.
14.
Blum, Kenneth, Thomas J.H. Chen, Bernard W. Downs, et al.. (2006). Genotrim™, a DNA-customized nutrigenomic product, targets genetic factors of obesity: Hypothesizing a dopamine–glucose correlation demonstrating reward deficiency syndrome (RDS). Medical Hypotheses. 68(4). 844–852. 31 indexed citations
15.
Braverman, Eric R., Thomas J.H. Chen, John Schoolfield, et al.. (2006). Delayed P300 latency correlates with abnormal Test of Variables of Attention (TOVA) in adults and predicts early cognitive decline in a clinical setting. Advances in Therapy. 23(4). 582–600. 18 indexed citations
16.
Blum, Kenneth, Thomas J.H. Chen, Bernard W. Downs, et al.. (2006). Reward deficiency syndrome in obesity: A preliminary cross-sectional trial with a genotrim variant. Advances in Therapy. 23(6). 1040–1051. 44 indexed citations
17.
Blum, Kenneth, Nicholas A. DiNubile, Thomas J.H. Chen, et al.. (2006). H-wave®, a nonpharmacologic alternative for the treatment of patients with chronic soft tissue inflammation and neuropathic pain: A preliminary statistical outcome study. Advances in Therapy. 23(3). 446–455. 12 indexed citations
18.
Blum, Kenneth, Thomas J.H. Chen, Manuel Martínez Pons, et al.. (2006). The H-Wave® small muscle fiber stimulator, a nonpharmacologic alternative for the treatment of chronic soft-tissue injury and neuropathic pain: an extended population observational study. Advances in Therapy. 23(5). 739–749. 10 indexed citations
19.
Blum, Kenneth, et al.. (2006). Nutrigenomics and pharmacogenomics: a scientific wonderland. Social Science Information. 45(1). 35–52. 4 indexed citations
20.
Comings, David E., et al.. (2005). Neurogenetic interactions and aberrant behavioral co-morbidity of attention deficit hyperactivity disorder (ADHD): dispelling myths. Theoretical Biology and Medical Modelling. 2(1). 50–50. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mallory Kerner Breakdown of academic impact, for papers by Roger L. Waite Breakdown of academic impact, for papers by John Giordano Breakdown of academic impact, for papers by Andrea Dlugos Breakdown of academic impact, for papers by Jeffrey L. Rausch Breakdown of academic impact, for papers by Aram El Khoury Breakdown of academic impact, for papers by Dorottya Pap Breakdown of academic impact, for papers by Hristina Jovanovic Breakdown of academic impact, for papers by J. Stastny Breakdown of academic impact, for papers by Klas R. Linderholm
Rankless by CCL
2026